HeartMate 3 LVAD

With Full Maglev Flow Technology

Product Advisories

Medical Device Correction: HeartMate 3 System Controller — July 2024

Abbott is notifying customers of a potential issue identified with HeartMate 3™ System Controllers. Abbott has identified that there is a potential for the specific controllers to have a lifted User Interface (UI) membrane that when present, is observed along the edge of the controller housing, near the Display Button. The product is not being removed from the field. This letter contains important information and recommendations regarding this issue.

Product Information Letter: HeartMate 3 Electrostatic Discharge Awareness — July 2024

Abbott notified customers about air fluidized specialty beds as a potential source of static electricity and the possible impact on functionality of the HeartMate 3™ LVAS. This letter enhances information already in the Instructions for Use. Alternatives to air fluidized specialty beds should be considered when using the HeartMate 3 LVAS.

Medical Device Correction: HeartMate System Monitor – May 2024

Abbott notified customers regarding complaints received for the HeartMate™ System Monitor where the screen may display atypical behavior. The distributed letter provides recommendations and guidance to follow if screen issues are observed. The System Monitor is not being removed from the field and does not need to be returned to Abbott.

Medical Device Correction: HeartMate 3 LVAS Kits – March 2024

Abbott is notifying customers of complaints of blood leaking out of the left ventricle or air entering the left ventricle or LVAD at the seal interface between the HeartMate 3™ LVAS inflow cannula and the titanium apical cuff. The blood leak or air entrainment has only been observed during the implantation procedure. The letter contains important information when observing blood leaking from the LVAD or air passing into the left ventricle and LVAD. There is no need to return any product to Abbott.

Medical Device Correction: HeartMate LVAS Kits and Outflow Grafts – February 2024

Abbott is notifying customers of a planned update to our Instructions for Use associated with observed outflow graft deformation known as “Extrinsic Outflow Graft Obstruction” (EOGO) associated with the HeartMate 3 Left Ventricular Assist System (LVAS) and HeartMate II™ LVAS. The letter contains important information on how to recognize EOGO and recommended steps to diagnose EOGO. There is no need to return any product to Abbott.

Medical Device Correction: HeartMate Touch Communication System – January 2024

An urgent Medical Device Correction was issued on January 3, 2024, indicating that the HeartMate Touch™ Communication System Application Ver. 1.0.32  could result in an unintentional start/stop of the HeartMate 3 Left Ventricle Asist Device (LVAD)

Medical Device Correction: HeartMate 3 LVAS Kits and Apical Coring Knife - August 2023

Abbott is notifying customers of a finding with the HeartMate Apical Coring Knife provided with the HeartMate 3 Left Ventricular Assist System (LVAS) kits and distributed separately.

The specific impacted serial numbers are listed on the links below. Please review Appendix A as of August 2023, Appendix A Expanded Scope as of September 2023, and Appendix A Expanded Scope as of October 2023 for the specific serial numbers within the scope of this notification.

MAT-2012391 v9.0